The Global Urinary Tract Obstruction Treatment Devices Market to Surge at CAGR of ~5% by 2027 | DelveInsight

New York, USA, Jan. 12, 2023 (GLOBE NEWSWIRE) — The Global Urinary Tract Obstruction Treatment Devices Market to Surge at CAGR of ~5% by 2027 | DelveInsight

The urinary tract obstruction treatment devices market is growing due to an increase in the prevalence of urological disorders such as bladder cancer, benign prostatic hyperplasia, urolithiasis, and nephrolithiasis. Innovation in product design, the increasing geriatric population, and an increase in the number of surgical procedures are all contributing to the growth of the urinary tract obstruction treatment devices market.

DelveInsight’s Urinary Tract Obstruction Treatment Devices Market Insights report provides the current and forecast market analysis, individual leading urinary tract obstruction treatment devices companies’ market shares, challenges, urinary tract obstruction treatment devices market drivers, barriers, and trends, and key urinary tract obstruction treatment devices companies in the market.

Key Takeaways from the Urinary Tract Obstruction Treatment Devices Market Report

• As per DelveInsight estimates, North America is anticipated to dominate the global urinary tract obstruction treatment devices market during the forecast period. 
• Notable urinary tract obstruction treatment devices companies such as B. Braun Melsungen AG, Boston Scientific Corporation, Cook, Becton, Dickinson, and Company, Teleflex Incorporated, Olympus, Dornier Medtech, EMS Urology, Advin Health Care, Inceler Medikal Co. Ltd., STORZ MEDICAL AG, Shockwave Medical Inc., ACE Medical Devices Pvt. Ltd., Walz Elektronik GmbH, Applied Medical Resources Corporation, Richard Wolf GmbH, Stryker, Urocare Products, Inc., J and M Urinary Catheters LLC, Rocamed, and several others are currently operating in the urinary tract obstruction treatment devices market.
• In December 2022, Minze Health announced a €3.9M investment from White Fund, Capricorn Partners, and PMV to scale its digital health solutions for the treatment of urinary tract problems.
• In October 2022, Teleflex Incorporated, a leading global provider of medical technologies, announced that new data published in the peer-reviewed Journal of Endourology show that the UroLift® System’s minimally invasive Prostatic Urethral Lift (PUL) procedure yields consistent safety, effectiveness, and patient experience outcomes for benign prostatic hyperplasia (BPH) with and without obstructive median lobes.
• In March 2021, Boston Scientific acquired Lumenis in a $1.07 billion deal. With this acquisition, Boston Scientific has strengthened its product portfolio for Lithotripsy devices. This will further add to the growth of the Global Urinary Tract Obstruction Treatment Devices market.
• In March 2021, Dornier MedTech GmbH became the world’s first integrated urology company to be certified by the European Union’s Medical Device Regulation (MDR). Dornier achieved the certification for its Class IIb products:  Dornier Delta® III, one of the most powerful lithotripters that utilize Dornier’s Extracorporeal Shock Wave Lithotripsy (ESWL) technology; and the Dornier UIMS™, a state-of-the-art information management software providing enhanced imaging and efficiency to support clinicians in treating kidney stones.

To read more about the latest highlights related to the urinary tract obstruction treatment devices market, get a snapshot of the key highlights entailed in the Global Urinary Tract Obstruction Treatment Devices Market Report

Urinary Tract Obstruction Treatment Devices Overview

Ureteral obstruction, also known as urinary tract obstruction, is a complete or partial blockage of the urinary tract. Urine may reflux backward into the kidneys because of ureteral obstruction. Ureteral obstruction is curable, but if not treated, it can result in kidney function loss, sepsis, and death. Kidney stones and urinary tract infections are also serious consequences. Mild symptoms of partial blockage include pain on one side, abnormal urine flow, and frequent, acute stinging pain, among other things. Urinary tract obstruction treatment devices are used to treat obstructions in the urine’s path from the kidney to the urethra.

Urinary Tract Obstruction Treatment Devices Market Insights

North America accounted for the largest share of the global urinary tract obstruction treatment devices market in 2021 out of all regions, and it is anticipated to dominate in the future. Factors such as the increasing prevalence of urological disorders such as bladder and prostate cancers, urolithiasis, or nephrolithiasis, among others, as well as the increased risk of end-stage renal failure in the population, as well as rising product approvals, are expected to aid in the growth of the North American urinary tract obstruction treatment devices market.

To know more about why North America is leading the market growth in the urinary tract obstruction treatment devices market, get a snapshot of the Urinary Tract Obstruction Treatment Devices Market Outlook 

Urinary Tract Obstruction Treatment Devices Market Dynamics

The urinary tract obstruction treatment devices market is experiencing increased product demand for a variety of reasons. The key factor is the increasing prevalence of urological disorders such as bladder cancer, benign prostatic hyperplasia, urolithiasis, and nephrolithiasis around the world. Furthermore, an increase in a sedentary lifestyle, such as excessive alcohol consumption and less water consumption, can lead to the development of kidney stones. Moreover, the rising prevalence of obesity among the population, which is a higher risk factor for the development of renal calculi due to sedentary lifestyles, such as poor dietary habits and a lack of physical activity, will contribute to the growth of the urinary tract obstruction treatment devices market.

However, certain factors, such as the high cost of devices and adverse events, may be limiting factors for the growth of the urinary tract obstruction treatment devices market.

Additionally, the COVID-19 pandemic resulted in a significant decrease in emergency department visits. Furthermore, there was a delay in outpatient clinic appointments, necessitating the use of virtual or telephone clinics. These changes resulted in a significant backlog in treatment due to a lack of in-hospital beds, anesthesia or procedural slots, and healthcare professionals, negatively impacting the global urinary tract obstruction treatment devices market.

Get a sneak peek at the urinary tract obstruction treatment devices market dynamics @ Urinary Tract Obstruction Treatment Devices Market Dynamics Analysis

Urinary Tract Obstruction Treatment Devices Market Assessment

• Urinary Tract Obstruction Treatment Devices Market Segmentation
  • Market Segmentation By Product: Urinary Catheters (Indwelling/Foley Catheters, Intermittent Catheters, External Catheters), Urinary Stents, Shock Wave Lithotripters (Intracorporeal, Extracorporeal), Ureteroscopes (Semi-Rigid, Flexible), Resectoscopes, Stone Retrieval Devices, Laser Therapy Systems, Others
  • Market Segmentation By Indication: Cancers, Stones, Benign Prostatic Hyperplasia (BPH), Hydronephrosis, Others
  • Market Segmentation By End User: Hospitals, Ambulatory Surgical Centers, Others
  • Market Segmentation By Geography: North America, Europe, Asia-Pacific, and Rest of World
• Porter’s Five Forces Analysis, Product Profiles, Case Studies, KOL’s Views, Analyst’s View

Which MedTech key players in the urinary tract obstruction treatment devices market are set to emerge as the trendsetter explore @ Urinary Tract Obstruction Treatment Devices Companies 

Table of Contents 

Interested in knowing the urinary tract obstruction treatment devices market by 2027? Click to get a snapshot of the Urinary Tract Obstruction Treatment Devices Market Trends

Related Reports

Stress Urinary Incontinence Market

Stress Urinary Incontinence Market Insight, Epidemiology, and Market Forecast – 2032 report delivers an in-depth understanding of the market trends, market drivers, market barriers, and key stress urinary incontinence companies, including Adrian Gaspar, Gynamics LTD, Solace Therapeutics, Inc., among others.

Stress Urinary Incontinence Pipeline

Stress Urinary Incontinence Pipeline Insight – 2022 report provides comprehensive insights about the pipeline landscape, pipeline drug profiles, including clinical and non-clinical stage products, and the key stress urinary incontinence companies, including Adrian Gaspar, Gynamics LTD, Solace Therapeutics, Inc., among others.

Urinary Incontinence Pipeline

Urinary Incontinence Pipeline Insight – 2022 report provides comprehensive insights about the pipeline landscape, pipeline drug profiles, including clinical and non-clinical stage products, and the key urinary incontinence companies, including Ixaltis SA, Graminex LLC, KGK Science Inc., among others.

Urinary Incontinence Market

Urinary Incontinence Market Insight, Epidemiology, and Market Forecast – 2032 report delivers an in-depth understanding of the market trends, market drivers, market barriers, and key urinary incontinence companies, including Ixaltis SA, Graminex LLC, KGK Science Inc., among others.

Uncomplicated Urinary Tract Infections Market

Uncomplicated Urinary Tract Infections Market Insights, Epidemiology, and Market Forecast – 2032 report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, market share of the individual therapies, and key uncomplicated urinary tract infections companies, including Venatorx Pharmaceuticals, Allecra Therapeutics, Nabriva Therapeutics AG, MerLion Pharmaceuticals, among others.

Complicated Urinary Tract Infections Pipeline

Complicated Urinary Tract Infections Pipeline Insight – 2022 report provides comprehensive insights about the pipeline landscape, including clinical and non-clinical stage products and the key complicated urinary tract infections companies, including Spero Therapeutics, Wockhardt, Venatorx Pharmaceuticals, Allecra Therapeutics, among others.

Other Trending Reports

Treatment Resistant Depression Market | Advanced Renal Cell Carcinoma Market | Brain Cancer Market | Centronuclear Myopathy Market | Head And Neck Squamous Cell Carcinoma Market | Acquired Immunodeficiency Syndrome Market | Acute Intermittent Porphyria Market | Neurovascular Devices Market | Defibrillators Market | Ventricular Hypertrophy Market | Urolithiasis Market | Alopecia Areata Market | Autonomic Dysfunction Market | Acute Ischemic Stroke Ais Market | Adenoid Cystic Carcinoma Market | Aspergillosis Market | Biliary Atresia Market | Biliary Tumor Market | Chronic Inducible Urticaria Market | Chronic Insomnia Market | Critical Limb Ischemia Market | Endometriosis Pain Market | Generalized Anxiety Disorder Gad Market | Hallux Valgus Market | Hemophilia B Market | Immunologic Deficiency Syndrome Market | Neuroblastoma Market | Neuromodulation Devices Market | Neurovascular Thrombectomy Devices Market | Osteosarcoma Market | Pemphigus Vulgaris Market | Progressive Familial Intrahepatic Cholestasis Market | Pruritus Market | Radiation Toxicity Market | Pulmonary Hypertension Associated With Interstitial Lung Disease Market | Cluster Headaches Market | Foot And Ankle Devices Market | Intravenous Immunoglobulin Market | Bile Duct Neoplasm Market | Blood Glucose Monitoring Systems Market | Rett Syndrome Market | Tissue Heart Valves Market | Cardiac Biomarkers Testing Devices Market | Subscription Healthcare | Hepatorenal Syndrome Market | Central Venous Catheters Market | Continuous Renal Replacement Therapy Machines Market | Nonalcoholic Steatohepatitis Market | Necrotizing Enterocolitis Market | Cardiac Amyloidosis Market | Artificial Iris Market | Aortic Aneurysm Stent Grafts Market | Polypoidal Choroidal Vasculopathy Market | Adrenal Crisis Market | Hearing Implants Market | Image Guided Surgery Devices Market | Angioedema Market | Bladder Cancer Market 

Related Healthcare Services

Healthcare Consulting

Healthcare Competitive Intelligence Services

Healthcare Asset Prioritization Services

About DelveInsight

DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance.